Drug Type Monoclonal antibody |
Synonyms |
Target |
Action agonists, inhibitors |
Mechanism B2 receptor agonists(Bradykinin B2 receptor agonists), GSK-3β inhibitors(Glycogen synthase kinase-3 beta inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Preclinical | Canada | - | |
| Hypercholesterolemia | Preclinical | Canada | - | |
| Hypertension | Preclinical | Canada | - | |
| Influenza, Human | Preclinical | Canada | - | |
| Neoplasms | Preclinical | Canada | - | |
| Tularemia | Preclinical | Canada | - |






